Skip to content{"success":true,"data":{"id":"twse-mops-ciafc0","title":"代子公司Alvogen Pharma US Inc. 依「公開發行公司資金貸與及背書保證處理準則」 第二十二條第一項第二款規定公告","summary":"1.事實發生日:114/12/03 2.接受資金貸與之: (1)公司名稱:Alvogen Inc. (2)與資金貸與他人公司之關係: Alvogen Inc.為Alvogen Pharma US Inc. 100%持有之子公司 (3)資金貸與之限額(仟元):24,827,709 (4)原資金貸與之餘額(仟元):0 (5)本次新增資金貸與之金額(仟元):43,478,379 (6)是否為董事會授權董事長對同一貸與對象分次撥貸或循環動用之資金貸與:否 (7)迄事實發生日止資金貸與餘額(仟元):43,478,379 (8)本次新增資金貸與之原因: 因併入NAGH集團而新增 3.接受資金貸與公司所提供擔保品之: (1)內容: 無 (2)價值(仟元):0 4.接受資金貸與公司最近期財務報表之: (1)資本(仟元):32…","canonicalUrl":"https://mops.twse.com.tw/mops/web/t05st01?TYPEK=all&co_id=1795&encodeURIComponent=1&firstin=1&inpuType=co_id&off=1&step=1&year=115&spoke_date=20261016&spoke_time=150557","sourceName":"TWSE Market Observation Post System","sourceUrl":"https://mops.twse.com.tw/mops/web/t05st01","publishedAt":"2026-10-16T07:05:57.000Z","updatedAt":null,"language":"zh-TW","timeZone":"Asia/Taipei","region":"taiwan","country":"TW","market":"Taiwan","topics":["company-announcement","taiwan"],"relatedAssets":["1795"],"importance":"normal","image":null,"imageRights":null,"contentType":"company-announcement","disclosure":"Official company announcement from 美時; use the filtered MOPS search page to verify the complete filing.","provenance":{"sourceId":"twse-mops","sourceType":"exchange","official":true,"verification":"PRIMARY_SOURCE_METADATA","fetchedAt":"2026-10-16T23:41:39.195Z","stale":false,"archived":true,"classificationMethod":"RULE_BASED"}},"meta":{"generatedAt":"2026-10-16T23:42:14.218Z","providers":[{"id":"jiguang-news-archive","name":"GOOSUN FINANCE source archive","kind":"news","provider":"goosun_finance","legacy_provider_alias":["jiguang","jiguang_finance"],"status":"available","itemCount":1,"cache":"HIT","fetchedAt":"2026-10-16T23:41:39.195Z","sourceUrl":"https://goosun.uk/sources.html","message":"Archived publisher metadata; original publication and fetch times retained. Archive availability is not source freshness."}],"stale":false,"apiVersion":"v2"},"error":null}